Lymphangioleiomyomatosis is a rare disease characterised by cystic destruction of the lung, lymphatic abnormalities and abdominal tumours. It affects almost exclusively females and can occur sporadically or in patients with tuberous sclerosis complex. In the past decade remarkable progress has been made in understanding of the pathogenesis of this disease leading to a new therapeutic approach. This review summarises recent advances regarding pathogenic mechanisms and clinical manifestations, and highlights the current and the most promising future therapeutic strategies.
The changing face of a rare disease: Lymphangioleiomyomatosis / S. Harari, O. Torre, R. Cassandro, J. Moss. - In: EUROPEAN RESPIRATORY JOURNAL. - ISSN 0903-1936. - 46:5(2015), pp. 1471-1485. [10.1183/13993003.00412-2015]
The changing face of a rare disease: Lymphangioleiomyomatosis
S. Harari;
2015
Abstract
Lymphangioleiomyomatosis is a rare disease characterised by cystic destruction of the lung, lymphatic abnormalities and abdominal tumours. It affects almost exclusively females and can occur sporadically or in patients with tuberous sclerosis complex. In the past decade remarkable progress has been made in understanding of the pathogenesis of this disease leading to a new therapeutic approach. This review summarises recent advances regarding pathogenic mechanisms and clinical manifestations, and highlights the current and the most promising future therapeutic strategies.| File | Dimensione | Formato | |
|---|---|---|---|
|
1471.full.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
720.76 kB
Formato
Adobe PDF
|
720.76 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in AIR sono rilasciati con licenza CCO mentre i file delle pubblicazioni sono rilasciati con licenza CC BY-SA, salvo diversa indicazione. In caso di violazione di copyright, contattare l'assistenza di AIR




